The effect of etrasimod on faecal calprotectin and high-sensitivity C-reactive protein: Results from the ELEVATE UC clinical programme

被引：0

作者：

Jairath, V. ^{[1
,2
]}

Rubin, D. T. ^{[3
]}

Verstockt, B. ^{[4
,5
]}

Cekin, A. H. ^{[6
]}

Abreu, M. T. ^{[7
]}

Lees, C. W. ^{[8
,9
]}

Fellmann, M. ^{[10
]}

Woolcott, J. C. ^{[11
]}

Crosby, C. ^{[12
]}

Wu, J. ^{[13
]}

Bhattacharjee, A. ^{[14
]}

Herman, D. ^{[12
]}

Gu, G. ^{[12
]}

Siegmund, B. ^{[15
,16
,17
,18
]}

机构：

[1] Western Univ, Dept Med, London, ON, Canada

[2] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada

[3] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Sect Gastroenterol Hepatol & Nutr, Chicago, IL USA

[4] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium

[5] Katholieke Univ Leuven, Translat Res GI Disorders, Dept Chron Dis & Metab, Leuven, Belgium

[6] Univ Hlth Sci, Antalya Training & Res Hosp, Dept Gastroenterol, Antalya, Turkiye

[7] Univ Miami, Miller Sch Med, Dept Med, Crohns & Colitis Ctr,Div Gastroenterol, Miami, FL 33136 USA

[8] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland

[9] NHS Lothian, Western Gen Hosp, Edinburgh IBD Unit, Edinburgh, Midlothian, Scotland

[10] Pfizer AG, Zurich, Switzerland

[11] Pfizer Inc, Collegeville, PA USA

[12] Pfizer Inc, La Jolla, CA USA

[13] Pfizer Inc, Cambridge, MA USA

[14] Pfizer Healthcare India Pvt Ltd, Chennai, Tamil Nadu, India

[15] Charite Univ Med Berlin, Med Klin Gastroenterol Infektiol Rheumatol, Berlin, Germany

[16] Free Univ Berlin, Berlin, Germany

[17] Humboldt Univ, Berlin, Germany

[18] Campus Benjamin Franklin, Berlin, Germany

来源：

JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P788

引用

页码：I1458 / I1460

页数：3

共 50 条

[1] The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical Program
Jairath, Vipul
Rubin, David T.
Verstockt, Bram
Cekin, Ayhan H.
Abreu, Maria T.
Lees, Charlie W.
Fellmann, Marc
Woolcott, John C.
Crosby, Catherine
Wu, Joseph
Bhattacharjee, Abhishek
Herman, David
Gu, Guibao
Siegmund, Britta
INFLAMMATORY BOWEL DISEASES, 2024,
[2] THE EFFECT OF ETRASIMOD ON FECAL CALPROTECTIN AND HIGHSENSITIVITY C-REACTIVE PROTEIN: RESULTS FROM THE ELEVATE UC CLINICAL PROGRAM
Jairath, Vipul
Rubin, David T.
Verstockt, Bram
Cekin, Ayhan Hilmi
Abreu, Maria T.
Lees, Charlie W.
Fellmann, Marc
Woolcott, John
Crosby, Catherine
Wu, Joseph
Bhattacharjee, Abhishek
Herman, David
Gu, Guibao
Siegmund, Britta
GASTROENTEROLOGY, 2024, 166 (05) : S816 - S816
[3] High-sensitivity C-reactive protein: Clinical importance
Bassuk, SS
Rifai, N
Ridker, PM
CURRENT PROBLEMS IN CARDIOLOGY, 2004, 29 (08) : 439 - 493
[4] C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians
Windgassen, Elizabeth B.
Funtowicz, Luciana
Lunsford, Tisha N.
Harris, Lucinda A.
Mulvagh, Sharon L.
POSTGRADUATE MEDICINE, 2011, 123 (01) : 114 - 119
[5] Effect of delayed processing on high-sensitivity C-reactive protein
Link, LB
Jacobson, JS
CLINICAL CHEMISTRY, 2006, 52 (04) : 787 - 788
[6] The effect of lifestyle changes on high-sensitivity C-reactive protein
Smith, Rahsaan
Mehta, Amish
Seigneur, David
Vido, Diane
Shannon, Richard
Murali, Srinivas
CIRCULATION, 2007, 115 (08) : E271 - E272
[7] High-Sensitivity C-Reactive Protein and Cancer
Lee, Seounghee
Choe, Jae-Won
Kim, Hong-Kyu
Sung, Joohon
JOURNAL OF EPIDEMIOLOGY, 2011, 21 (03) : 161 - 168
[8] What is high-sensitivity C-reactive protein?
Conti, CR
CLINICAL CARDIOLOGY, 2001, 24 (10) : 639 - 640
[9] High-sensitivity C-reactive protein in psoriasis
Nisa, Nuzhatun
Ahmed, Qazi
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2012, 51 (11) : 1393 - 1394
[10] Agreement between high-sensitivity C-reactive protein and C-reactive protein assays
Han, E.
Fritzer-Szekeres, M.
Szekeres, T.
Anvari-Pirsch, A.
Gyoengyoesi, M.
Bergler-Klein, J.
EUROPEAN HEART JOURNAL, 2021, 42 : 1084 - 1084

← 1 2 3 4 5 →